Vivek Garipalli

Founder / Exec Chair @ Clover Health (Nasdaq: CLOV) - wormholecap.com

📍 New York, New York, United States🔄 Updated September 2026💼 8 investments📅 19 years investing🗓 Last invested Aug 2020
VC🌍 United States
8
Total investments
7
Early stage
0
Mid stage
0
Late stage
19y
Years active

Portfolio

8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member & Investor/Advisor
Aug 2020
Thyme Care is a value-based oncology management platform whose mission is to improve the quality of life for people diagnosed with cancer by providing personalized, clinically coordinated care. Thyme Care pairs human guidance with software and analytics to quickly connect members to the right care and provide ongoing support through targeted, evidence-based interventions. Founded by oncology industry veterans and clinicians, the companys approach prioritizes deep provider relationships and integrates with a health plan’s existing infrastructure, coordinating value-driven care that leads to better outcomes, lower costs, and an improved member experience. Backed with venture funding from Andreessen Horowitz (a16z), AlleyCorp, Frist Cressey Ventures, Casdin Capital, and Bessemer, Thyme Care partners with health insurance plans and providers to extend the reach of high-quality cancer care through flexible value-based payment arrangements, including risk-based programs. To learn more about how Thyme Care is unlocking high-value care in oncology, visit www.thymecare.com.
Board Member
Aug 2018
Character Biosciences is a precision medicine company transforming drug development for progressive, polygenic diseases, beginning with ophthalmology. Our mission is to identify the genetic and molecular drivers of disease progression so we can develop targeted therapies for patients who urgently need them. Weve built one of the most comprehensive resources in age-related eye diseases by partnering with over 150 ophthalmology clinics to integrate genetics with longitudinal clinical and imaging data. This deep phenotyping approach enables us to reclassify complex diseases like age-related macular degeneration (AMD) into genetically defined subtypes, unlocking novel therapeutic targets and optimizing patient selection for clinical trials. Character Bio’s AI-powered platform combines genomics, multi-modal data, and machine learning to discover and develop therapies that are more precise and more effective. Our lead programs, CTX114 and CTX203, are advancing toward clinical trials and are designed to slow or prevent vision loss in AMD patients. We are committed to delivering a new generation of precision medicines to treat and ultimately cure age-related blindness.
early stageBiotechnology
Board Member & Investor/Advisor
Mar 2018
DispatchHealth and Medically Home have joined forces to create one of the nations largest hospital-at-home providers—delivering hospital-level care where patients feel most comfortable, at home.
Board Member/Observer & Investor/Advisor
Dec 2017
Cityblock was founded in 2017 as the first tech-driven provider for communities with complex needs. We deliver better care to where it’s needed most, investing upstream in highly personalized, prevention-oriented health and social care to ultimately drive down costs and improve outcomes. Our tech enables scale by bringing together practical information, coordination, and communication for our members and our care teams. We are adamant about building a radically better member experience for people living in lower-income neighborhoods that have never been prioritized. And we won’t be satisfied with anything less than transforming the way that health services are delivered in previously underserved communities across the U.S. Join us! cityblock.com/careers
Co-Founder & Board Member
May 2014
Ensemble manages more than $47 billion in net patient revenue (NPR) and partners with more unique health systems than any other revenue cycle firm to deliver holistic financial health solutions through end-to-end managed services partnerships. The firm helps providers maximize their current technology and deploys industry-leading solutions to meet the unique needs of their systems and patients. Ensemble focuses on delivering value quickly and sustaining high performance, meeting 100% of year-one client goals, exceeding 102% of year-one cash collections and delivering 5% average NPR lift across clients.
Co-Founder, CEO & Board Member
Oct 2012
Clover Health (Nasdaq: CLOV) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare We aim to provide great care, in a sustainable way, by having a business model built around improving medical outcomes while lowering avoidable costs. We do this while taking a holistic approach to understanding the health needs and social risk factors of those under our care. This strategy is underpinned by our proprietary software platform, the Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making by presenting physicians and other providers with real-time, personalized recommendations at the point of care. Making care more accessible is at the heart of our business, and we believe patients should have the freedom to choose their doctors. We offer affordable Medicare Advantage plans with extensive benefits, provide primary care physicians with the Clover Assistant, and also make comprehensive home-based care available via the Clover Home Care program. With our corporate headquarters in Nashville, Clover’s workforce is distributed around the U.S. and also includes a team of world-class technologists based in Hong Kong. We manage care for Medicare Advantage members in Alabama, Arizona, Georgia, Mississippi, New Jersey, Pennsylvania, South Carolina, Tennessee, and Texas. We are hiring software engineers, data scientists, designers and product folks who can help us understand our members’ wellness and steer them clear of any health risks down the road. If you’re a passionate person and interested in changing healthcare for the better, then Clover Health may just be the place for you.
Board Member & Advisor/Investor
Jun 2012
Flatiron Health’s mission is to improve and extend lives by learning from the experience of every person with cancer.
Experience · 11 entries
All (11)
Investments (6)
Founder (3)
Board (1)
2020
Board Member & Investor/Advisor
Aug 2020
Thyme Care is a value-based oncology management platform whose mission is to improve the quality of life for people diagnosed with cancer by providing personalized, clinically coordinated care. Thyme Care pairs human guidance with software and analytics to quickly connect members to the right care and provide ongoing support through targeted, evidence-based interventions. Founded by oncology industry veterans and clinicians, the companys approach prioritizes deep provider relationships and integrates with a health plan’s existing infrastructure, coordinating value-driven care that leads to better outcomes, lower costs, and an improved member experience. Backed with venture funding from Andreessen Horowitz (a16z), AlleyCorp, Frist Cressey Ventures, Casdin Capital, and Bessemer, Thyme Care partners with health insurance plans and providers to extend the reach of high-quality cancer care through flexible value-based payment arrangements, including risk-based programs. To learn more about how Thyme Care is unlocking high-value care in oncology, visit www.thymecare.com.
2018
Board Member
Aug 2018
Character Biosciences is a precision medicine company transforming drug development for progressive, polygenic diseases, beginning with ophthalmology. Our mission is to identify the genetic and molecular drivers of disease progression so we can develop targeted therapies for patients who urgently need them. Weve built one of the most comprehensive resources in age-related eye diseases by partnering with over 150 ophthalmology clinics to integrate genetics with longitudinal clinical and imaging data. This deep phenotyping approach enables us to reclassify complex diseases like age-related macular degeneration (AMD) into genetically defined subtypes, unlocking novel therapeutic targets and optimizing patient selection for clinical trials. Character Bio’s AI-powered platform combines genomics, multi-modal data, and machine learning to discover and develop therapies that are more precise and more effective. Our lead programs, CTX114 and CTX203, are advancing toward clinical trials and are designed to slow or prevent vision loss in AMD patients. We are committed to delivering a new generation of precision medicines to treat and ultimately cure age-related blindness.
early stageBiotechnology
Board Member & Investor/Advisor
Mar 2018
DispatchHealth and Medically Home have joined forces to create one of the nations largest hospital-at-home providers—delivering hospital-level care where patients feel most comfortable, at home.
2017
Board Member/Observer & Investor/Advisor
Dec 2017
Cityblock was founded in 2017 as the first tech-driven provider for communities with complex needs. We deliver better care to where it’s needed most, investing upstream in highly personalized, prevention-oriented health and social care to ultimately drive down costs and improve outcomes. Our tech enables scale by bringing together practical information, coordination, and communication for our members and our care teams. We are adamant about building a radically better member experience for people living in lower-income neighborhoods that have never been prioritized. And we won’t be satisfied with anything less than transforming the way that health services are delivered in previously underserved communities across the U.S. Join us! cityblock.com/careers
2014
Co-Founder & Board Member
May 2014
Ensemble manages more than $47 billion in net patient revenue (NPR) and partners with more unique health systems than any other revenue cycle firm to deliver holistic financial health solutions through end-to-end managed services partnerships. The firm helps providers maximize their current technology and deploys industry-leading solutions to meet the unique needs of their systems and patients. Ensemble focuses on delivering value quickly and sustaining high performance, meeting 100% of year-one client goals, exceeding 102% of year-one cash collections and delivering 5% average NPR lift across clients.
Show all 11 entries ↓
Investment activity
2007–2020 · 8 investments
200712012220141201712018220201
Recent (last 2 years)Earlier